Annual Drug Patent Expirations for AXIRON
Axiron is a drug marketed by Eli Lilly And Co
and is included in one NDA. It is available from two suppliers. There are eleven patents protecting this drug and one Paragraph IV challenge.
This drug has eigthy-three patent family members in twenty countries.
The generic ingredient in AXIRON is testosterone. Two suppliers are listed for this compound. Additional details are available on the testosterone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit www.DrugPatentWatch.com